Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL admixed with bupivacaine HCl for postsurgical analgesia in TKA
NCT05139030Phase 3Completed
- Sponsor
- Pacira BioSciences
- Start
- Jan 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal bupivacaine in postoperative pain, sponsored by Pacira BioSciences. Started Jan 2022; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05139030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05139030.